Survival Rate after Pulmonary Metastasectomy in Bone and Soft Tissue Sarcoma.
- Author:
Yong Koo KANG
;
Seung Koo LEE
;
Jung Man KIM
;
Hoon Kyo KIM
;
Kun Hyun CHO
;
Young Hoon KIM
- Publication Type:Original Article
- Keywords:
Bone and Soft Tissue Sarcoma;
Metastasectomy;
Survival rate
- MeSH:
Drug Therapy;
Follow-Up Studies;
Humans;
Korea;
Metastasectomy*;
Neoplasm Metastasis;
Sarcoma*;
Survival Rate*
- From:The Journal of the Korean Orthopaedic Association
1997;32(1):223-228
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
We investigated the overall survival rate after pulmonary metastasectomy in the bone and soft tissue sarcoma and the available prognostic factors related with the survival rate after pulmonary metastasectomy. Between 1986 and 1995, 9 patients (median age 32) with bone and soft tissue sarcoma with pulmonary metastasis were managed in the Catholic University of Korea. Until the final follow-up in May 1996, 6 patients have died of disease and their mean survival period was 28 months (9- 58months). The actual 5-year survival rate by Kaplan-Meier method was 33%. Prognostic factors such as tumor free interval, number of metastatic lesion, postoperative chemotherapy and histologic grade were analyzed. Three patients who had the tumor free interval over 3 years were alive (mean survival period: 52.6 months), whereas six patients who had the tumor free interval less than 3 years were dead (mean survival period: 19 months). Out of four patients with low grade tumor, three patients were alive with average 39.2 months survival period, whereas five patients with high grade tumor were all dead with average 19.2 months survival period. These results suggested that pulmonary metastasectomy in bone and soft tissue sarcoma may prolong the survival rate. The long tumor free interval, histological low grade and soft tissue sarcoma may influenced on prolonged survival rate. However, number of metastatic lesion or postoperative chemotherapy has not influenced on the survival rate.
